Relationship between patient decision-making on advanced therapies and patient background in patients with ulcerative colitis

Relationship between patient decision-making on advanced therapies and patient background in patients with ulcerative colitis - Relationship between patient decision-making on advanced therapies and patient background in patients with ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052327

Enrollment

400

Registered

2023-09-27

Start date

2023-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis (UC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: No matching the key inclusion criteria Participants who expressed nonparticipation in the study prior to data fixation

Design outcomes

Primary

Measure	Time frame
Importance of drug profiles \x{00a0}(mode of administration, efficacy, adverse events, and timing of launches) by patient background (demographics, disease activity, treatment of UC, employment status, status of employees, status of students, and other life events)	—

Countries

Japan

Contacts

Public ContactYoko Kawasaki

QLife, Inc. Strategic Solution Planning & Development Dept

office_2@qlife.co.jp03-6860-5020

Outcome results